scispace - formally typeset
A

Anak Agung Bagus Putra Indrakusuma

Researcher at Udayana University

Publications -  5
Citations -  3

Anak Agung Bagus Putra Indrakusuma is an academic researcher from Udayana University. The author has contributed to research in topics: Medicine & Odds ratio. The author has co-authored 3 publications.

Papers
More filters
Journal ArticleDOI

The association between smartphone addiction and insomnia incidence in students of the faculty of medicine udayana university batch of 2020 during the coronavirus disease-19 pandemic

TL;DR: In this paper, a study was conducted to find an association between smartphone addiction and the incidence of insomnia, especially among students of the Faculty of Medicine, Udayana University, in Sri Lanka.
Journal ArticleDOI

The Risk of Antipsychotic Drugs on Breast Cancer: A Systematic Review and Meta-analysis

TL;DR: In this paper, a systematic review and meta-analysis study was conducted to investigate the association between the consumption of antipsychotic drugs and breast cancer, which showed no significant association between overall use of the drugs and the incidence of breast cancer (odds ratio = 1.06; 95% CI: 0.94-1.19; p = 0.36).
Journal ArticleDOI

The impact of the COVID-19 pandemic on the readiness of last year's medical students for clinical rotation

TL;DR: In this paper, the impact of the coronavirus disease (COVID-19) pandemic on the readiness of last year's medical students for clinical rotation was discussed, which had a substantial impact on medical student education, especially on interruptions of student assistantship that disturb students' preparation, self-assurance and professional identity.
Journal ArticleDOI

The Risk of Antihypertensive Drug among Breast Cancer Patient: A Systematic Review and Meta-analysis

TL;DR: In this paper, a systematic review and meta-analysis of current evidence was conducted to compare the use of anti-hypertensive drugs as a risk factor for breast cancer, which revealed that anti-drugs (diuretics, β-blockers, calcium channel blockers, and diuretics) in overall are significant for the risk of breast cancer and also found that ARBs have a low potential in the risk.